CASMED and Century Medical Execute Distribution Agreement for FORE-SIGHT(R) Oximeters in Japan

CASMED and Century Medical Execute Distribution Agreement for FORE-SIGHT(R)
Oximeters in Japan

Shipments Expected to Begin in the Third Quarter, Following Receipt of
Regulatory Approval

BRANFORD, Conn., May 29, 2014 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc.
(Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient
monitoring, today announced that it has signed an agreement with Century
Medical, Inc. to serve as the exclusive distributor of the Company's
FORE-SIGHT ELITE® Cerebral Oximeters in Japan.

Century Medical has a 40-year history as a distributor of quality medical
products.Century Medical will sell the FORE-SIGHT oximetry products through
its cardiovascular division, which includes more than 25 field personnel
across seven offices.By bringing best-in-class products to their clinician
customers, Century Medical has a strong track record of success in building
and expanding markets with unique products from some of the world's leading
medtech companies.Century Medical is a subsidiary of ITOCHU Corporation,
Japan's third largest trading company.

"Establishing high-quality distribution with comprehensive reach in the
world's second-largest medical market represents another key milestone for our
Company," said Thomas Patton, CASMED's President and CEO."With an existing
product portfolio that is complementary to FORE-SIGHT oximetry along with
established relationships with key decision makers across Japan, Century
Medical is the ideal partner for us.In addition, they have a well-earned
reputation for providing innovative products supported by a high level of
customer service."

"We look forward to building a long-term relationship with CASMED and to
establishing the FORE-SIGHT ELITE Oximeter as the market leader in Japan,"
said Akira Hoshino, President and CEO of Century Medical."Many of our
customers are familiar with FORE-SIGHT oximetry from the body of literature
that has been published in support of the product and from its success in the
United States, and are keenly interested in gaining first-hand experience with
this best-in-class technology."

CASMED expects the regulatory approvals necessary to permit Century Medical to
market the product in Japan to be received early in the third quarter of
2014.

About CASMED^® – Monitoring What's Vital

CASMED is a leading developer and manufacturer of medical devices for
non-invasive patient monitoring that are vital to patient care. The Company's
FORE-SIGHT Absolute Cerebral Oximetry technology provides highly accurate,
non-invasive, continuous measurement of absolute cerebral tissue oxygen
saturation.Direct monitoring of tissue oxygenation provides a superior and
powerful tool to alert clinicians to otherwise unrecognized and dangerously
low levels of oxygenation of the brain and other tissues, thereby allowing
them to intervene appropriately in the care of their patients. In addition to
FORE-SIGHT Oximeters and accessories, the Company provides a line of bedside
patient vital signs monitoring products, proprietary non-invasive blood
pressure monitoring solutions for OEM use, neonatal intensive care supplies,
and service.
For further information regarding CASMED, visit the Company's website at
www.casmed.com.

Statements included in this press release, which are not historical in nature,
are forward-looking statements made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Statements relating to
the future performance of the Company are subject to many factors including,
but not limited to, the customer acceptance of the products in the market, the
introduction of competitive products and product development, the impact of
any product liability or other adverse litigation, working capital and
availability of capital, commercialization and technological difficulties, the
impact of actions and events involving key customers, vendors, lenders,
competitors, and other risks detailed in the Company's Form 10-K for the year
ended December 31, 2013, and other subsequent Securities and Exchange
Commission filings.

Such statements are based upon the current beliefs and expectations of the
Company's management and are subject to significant risks and uncertainties.
Actual results may differ from those set forth in the forward-looking
statements. When used in this press release, the terms "anticipate,"
"believe," "estimate," "expect," "may," "objective," "plan," "possible,"
"potential," "project," "will," and similar expressions identify
forward-looking statements. The forward-looking statements contained in this
press release are made as of the date hereof, and we do not undertake any
obligation to update any forward-looking statements, whether as a result of
future events, new information, or otherwise.

CONTACT: Company Contact
         CAS Medical Systems, Inc.
         Jeffery A. Baird
         Chief Financial Officer
         (203) 315-6303
         ir@casmed.com
        
         Investor Contact
         LHA
         Bruce Voss
         (310) 691-7100
         bvoss@lhai.com
         @LHA_IR_PR

CAS Medical Systems Logo
 
Press spacebar to pause and continue. Press esc to stop.